{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T07:42:43Z","timestamp":1767339763987,"version":"3.44.0"},"reference-count":99,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.amjmed.2022.05.009","type":"journal-article","created":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T20:59:05Z","timestamp":1653685145000},"page":"1168-1177.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Controversies in Hypertension II: The Optimal Target Blood Pressure"],"prefix":"10.1016","volume":"135","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3161-5820","authenticated-orcid":false,"given":"Edward J.","family":"Filippone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J.","family":"Foy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald V.","family":"Naccarelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10159","key":"10.1016\/j.amjmed.2022.05.009_bib0001","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1016\/S0140-6736(18)32225-6","volume":"392","year":"2018","journal-title":"Lancet"},{"issue":"9349","key":"10.1016\/j.amjmed.2022.05.009_bib0002","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","article-title":"Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies","volume":"360","author":"Lewington","year":"2002","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.amjmed.2022.05.009_bib0003","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1161\/01.HYP.0000075083.04415.4B","article-title":"Blood pressure indices and cardiovascular disease in the Asia Pacific region: a pooled analysis","volume":"42","author":"Lawes","year":"2003","journal-title":"Hypertension"},{"issue":"9","key":"10.1016\/j.amjmed.2022.05.009_bib0004","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1001\/jama.1997.03540330061036","article-title":"Health outcomes associated with antihypertensive therapies used as first-line agents. a systematic review and meta-analysis","volume":"277","author":"Psaty","year":"1997","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.amjmed.2022.05.009_bib0005","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1097\/00004872-200306000-00002","article-title":"Cardiovascular prevention and blood pressure reduction: a quantitative overview updated until 1 march 2003","volume":"21","author":"Staessen","year":"2003","journal-title":"J Hypertens"},{"key":"10.1016\/j.amjmed.2022.05.009_bib0006","doi-asserted-by":"crossref","first-page":"b1665","DOI":"10.1136\/bmj.b1665","article-title":"Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies","volume":"338","author":"Law","year":"2009","journal-title":"BMJ"},{"issue":"17","key":"10.1016\/j.amjmed.2022.05.009_bib0007","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1001\/jama.2018.16755","article-title":"The 2018 European Society of Cardiology\/European Society of Hypertension and 2017 American College Of Cardiology\/American Heart Association blood pressure guidelines: more similar than different","volume":"320","author":"Whelton","year":"2018","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.amjmed.2022.05.009_bib0008","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1161\/HYP.0000000000000066","volume":"71","author":"Whelton","year":"2018","journal-title":"Hypertension"},{"issue":"33","key":"10.1016\/j.amjmed.2022.05.009_bib0009","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH guidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.amjmed.2022.05.009_bib0010","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.kint.2020.10.026","article-title":"Executive summary of the KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease","volume":"99","author":"Cheung","year":"2021","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.amjmed.2022.05.009_bib0011","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3109\/08037059409102265","article-title":"The BBB study: The effect of intensified antihypertensive treatment on the level of blood pressure, side-effects, morbidity and mortality in \u201cwell-treated\u201d hypertensive patients","volume":"3","author":"Hansson","year":"1994","journal-title":"Blood Press"},{"issue":"7160","key":"10.1016\/j.amjmed.2022.05.009_bib0012","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1136\/bmj.317.7160.703","article-title":"Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK prospective diabetes study group","volume":"317","year":"1998","journal-title":"BMJ"},{"issue":"9118","key":"10.1016\/j.amjmed.2022.05.009_bib0013","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0140-6736(98)04311-6","article-title":"Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the hypertension optimal treatment (HOT) randomised trial. HOT study group","volume":"351","author":"Hansson","year":"1998","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.amjmed.2022.05.009_bib0014","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1291\/hypres.31.2115","article-title":"Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS)","volume":"31","year":"2008","journal-title":"Hypertens Res"},{"issue":"9689","key":"10.1016\/j.amjmed.2022.05.009_bib0015","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0140-6736(09)61340-4","article-title":"Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (cardio-sis): An open-label randomised trial","volume":"374","author":"Verdecchia","year":"2009","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.amjmed.2022.05.009_bib0016","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1161\/HYPERTENSIONAHA.109.146035","article-title":"Target blood pressure for treatment of isolated systolic hypertension in the elderly","volume":"56","author":"Ogihara","year":"2010","journal-title":"Hypertension"},{"issue":"17","key":"10.1016\/j.amjmed.2022.05.009_bib0017","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1001286","article-title":"Effects of intensive blood-pressure control in type 2 diabetes mellitus","volume":"362","author":"Cushman","year":"2010","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.amjmed.2022.05.009_bib0018","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/hr.2012.125","article-title":"Cardiovascular outcomes in the first trial of antihypertensive therapy guided by self-measured home blood pressure","volume":"35","author":"Asayama","year":"2012","journal-title":"Hypertension Research"},{"issue":"9891","key":"10.1016\/j.amjmed.2022.05.009_bib0019","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(13)60852-1","article-title":"Blood-pressure targets in patients with recent lacunar stroke: The SPS3 randomised trial","volume":"382","author":"Benavente","year":"2013","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.amjmed.2022.05.009_bib0020","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/jch.12094","article-title":"Effects of intensive antihypertensive treatment on Chinese hypertensive patients older than 70 years","volume":"15","author":"Wei","year":"2013","journal-title":"J Clin Hypertens"},{"issue":"23","key":"10.1016\/j.amjmed.2022.05.009_bib0021","first-page":"2294","article-title":"A randomized trial of intensive versus standard blood-pressure control","volume":"374","author":"Wright","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2022.05.009_bib0022","doi-asserted-by":"crossref","first-page":"i708","DOI":"10.1136\/bmj.i708","article-title":"Different systolic blood pressure targets for people with history of stroke or transient ischaemic attack: PAST-BP (prevention after stroke\u2013blood pressure) randomised controlled trial","volume":"352","author":"Mant","year":"2016","journal-title":"BMJ"},{"issue":"14","key":"10.1016\/j.amjmed.2022.05.009_bib0023","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1056\/NEJMoa2111437","article-title":"Trial of intensive blood-pressure control in older patients with hypertension","volume":"385","author":"Zhang","year":"2021","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1016\/j.amjmed.2022.05.009_bib0024","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJM199403313301301","article-title":"The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. modification of diet in renal disease study group","volume":"330","author":"Klahr","year":"1994","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.amjmed.2022.05.009_bib0025","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/ki.1995.361","article-title":"\"Strict\" blood pressure control and progression of renal disease in hypertensive nephrosclerosis","volume":"48","author":"Toto","year":"1995","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.amjmed.2022.05.009_bib0026","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0272-6386(99)70036-3","article-title":"Effect of intensive blood pressure control on the course of type 1 diabetic nephropathy. collaborative study group","volume":"34","author":"Lewis","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.amjmed.2022.05.009_bib0027","first-page":"B54","article-title":"Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes","volume":"23","author":"Estacio","year":"2000","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.amjmed.2022.05.009_bib0028","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1046\/j.1523-1755.2002.00213.x","article-title":"Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes","volume":"61","author":"Schrier","year":"2002","journal-title":"Kidney Int"},{"issue":"7","key":"10.1016\/j.amjmed.2022.05.009_bib0029","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1097\/01.ASN.0000018407.60002.B9","article-title":"Cardiac and renal effects of standard versus rigorous blood pressure control in autosomal-dominant polycystic kidney disease: Results of a seven-year prospective randomized study","volume":"13","author":"Schrier","year":"2002","journal-title":"J Am Soc Nephrol"},{"issue":"19","key":"10.1016\/j.amjmed.2022.05.009_bib0030","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1001\/jama.288.19.2421","article-title":"Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: Results from the AASK trial","volume":"288","author":"Wright","year":"2002","journal-title":"JAMA"},{"issue":"9463","key":"10.1016\/j.amjmed.2022.05.009_bib0031","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0140-6736(05)71082-5","article-title":"Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial","volume":"365","author":"Ruggenenti","year":"2005","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.amjmed.2022.05.009_bib0032","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.amjhyper.2006.05.011","article-title":"Effect of intensive blood pressure control with valsartan on urinary albumin excretion in normotensive patients with type 2 diabetes","volume":"19","author":"Estacio","year":"2006","journal-title":"Am J Hypertens"},{"issue":"24","key":"10.1016\/j.amjmed.2022.05.009_bib0033","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1402685","article-title":"Blood pressure in early autosomal dominant polycystic kidney disease","volume":"371","author":"Schrier","year":"2014","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.amjmed.2022.05.009_bib0034","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJMoa0902066","article-title":"Strict blood-pressure control and progression of renal failure in children","volume":"361","author":"W\u00fchl","year":"2009","journal-title":"N Engl J Med"},{"issue":"11 Pt 1","key":"10.1016\/j.amjmed.2022.05.009_bib0035","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0895-7061(03)01004-5","article-title":"Long-term effects of intensive blood-pressure lowering on arterial wall stiffness in hypertensive patients","volume":"16","author":"Ichihara","year":"2003","journal-title":"Am J Hypertens"},{"issue":"2","key":"10.1016\/j.amjmed.2022.05.009_bib0036","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1161\/HYPERTENSIONAHA.109.138529","article-title":"Effect of intensive versus standard blood pressure lowering on diastolic function in patients with uncontrolled hypertension and diastolic dysfunction","volume":"55","author":"Solomon","year":"2010","journal-title":"Hypertension"},{"issue":"19","key":"10.1016\/j.amjmed.2022.05.009_bib0037","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1161\/CIRCULATIONAHA.116.026230","article-title":"Effect of aggressive blood pressure control on the recurrence of atrial fibrillation after catheter ablation: a randomized, open-label clinical trial (SMAC-AF [substrate modification with aggressive blood pressure control])","volume":"135","author":"Parkash","year":"2017","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.amjmed.2022.05.009_bib0038","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1161\/STROKEAHA.120.032054","article-title":"PRESERVE: Randomized trial of intensive versus standard blood pressure control in small vessel disease","volume":"52","author":"Markus","year":"2021","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.amjmed.2022.05.009_bib0039","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1161\/HYPERTENSIONAHA.116.07257","article-title":"Unattended blood pressure measurements in the systolic blood pressure intervention trial: Implications for entry and achieved blood pressure values compared with other trials","volume":"67","author":"Kjeldsen","year":"2016","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.amjmed.2022.05.009_bib0040","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1001\/jamainternmed.2018.6551","article-title":"Comparing automated office blood pressure readings with other methods of blood pressure measurement for identifying patients with possible hypertension: A systematic review and meta-analysis","volume":"179","author":"Roerecke","year":"2019","journal-title":"JAMA Intern Med"},{"issue":"1","key":"10.1016\/j.amjmed.2022.05.009_bib0041","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11906-017-0700-y","article-title":"The un-observed automated office blood pressure measurement technique used in the SPRINT study points to a standard target office systolic blood pressure","volume":"19","author":"Kjeldsen","year":"2017","journal-title":"Curr Hypertens Rep"},{"issue":"5","key":"10.1016\/j.amjmed.2022.05.009_bib0042","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1161\/HYPERTENSIONAHA.117.10479","article-title":"Blood pressure measurement in SPRINT (systolic blood pressure intervention trial)","volume":"71","author":"Johnson","year":"2018","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.amjmed.2022.05.009_bib0043","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1681\/ASN.V122218","article-title":"Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) study","volume":"12","author":"Ruilope","year":"2001","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"10.1016\/j.amjmed.2022.05.009_bib0044","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/hr.2010.162","article-title":"Impact of renal function on cardiovascular events in elderly hypertensive patients treated with efonidipine","volume":"33","author":"Hayashi","year":"2010","journal-title":"Hypertension Research"},{"issue":"9","key":"10.1016\/j.amjmed.2022.05.009_bib0045","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1681\/ASN.2017020148","article-title":"Effects of intensive BP control in CKD","volume":"28","author":"Cheung","year":"2017","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"10.1016\/j.amjmed.2022.05.009_bib0046","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001293","article-title":"Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: A systematic review and meta-analysis","volume":"9","author":"Lv","year":"2012","journal-title":"PLoS Med"},{"issue":"10017","key":"10.1016\/j.amjmed.2022.05.009_bib0047","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0140-6736(15)00805-3","article-title":"Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis","volume":"387","author":"Xie","year":"2016","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.amjmed.2022.05.009_bib0048","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.amjmed.2017.01.004","article-title":"Optimal systolic blood pressure target after SPRINT: insights from a network meta-analysis of randomized trials","volume":"130","author":"Bangalore","year":"2017","journal-title":"Am J Med"},{"issue":"12","key":"10.1016\/j.amjmed.2022.05.009_bib0049","article-title":"Blood pressure targets in adults with hypertension","volume":"12","author":"Arguedas","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"10.1016\/j.amjmed.2022.05.009_bib0050","article-title":"Blood pressure targets for hypertension in people with diabetes mellitus","author":"Arguedas","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"10.1016\/j.amjmed.2022.05.009_bib0051","article-title":"Blood pressure targets for the treatment of people with hypertension and cardiovascular disease","volume":"9","author":"Saiz","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"10.1016\/j.amjmed.2022.05.009_bib0052","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1503\/cmaj.121468","article-title":"Effects of intensive blood pressure lowering on the progression of chronic kidney disease: A systematic review and meta-analysis","volume":"185","author":"Lv","year":"2013","journal-title":"CMAJ"},{"issue":"6","key":"10.1016\/j.amjmed.2022.05.009_bib0053","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1001\/jamainternmed.2017.0197","article-title":"Association of intensive blood pressure control and kidney disease progression in nondiabetic patients with chronic kidney disease: a systematic review and meta-analysis","volume":"177","author":"Tsai","year":"2017","journal-title":"JAMA Intern Med"},{"issue":"10","key":"10.1016\/j.amjmed.2022.05.009_bib0054","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1001\/jamainternmed.2017.4377","article-title":"Association between more intensive vs less intensive blood pressure lowering and risk of mortality in chronic kidney disease stages 3 to 5: a systematic review and meta-analysis","volume":"177","author":"Malhotra","year":"2017","journal-title":"JAMA Intern Med"},{"issue":"6","key":"10.1016\/j.amjmed.2022.05.009_bib0055","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1161\/HYPERTENSIONAHA.119.12697","article-title":"Mortality outcomes with intensive blood pressure targets in chronic kidney disease patients","volume":"73","author":"Aggarwal","year":"2019","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.amjmed.2022.05.009_bib0056","doi-asserted-by":"crossref","first-page":"430","DOI":"10.7326\/M16-1785","article-title":"Pharmacologic treatment of hypertension in adults aged 60 years or older to higher versus lower blood pressure targets: a clinical practice guideline from the american college of physicians and the American Academy of Family Physicians","volume":"166","author":"Qaseem","year":"2017","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.amjmed.2022.05.009_bib0057","first-page":"506","article-title":"Hypertension Canada's 2018 guidelines for diagnosis, risk assessment, prevention, and treatment of hypertension in adults and children","volume":"34","author":"Nerenberg","year":"2018","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.amjmed.2022.05.009_bib0058","doi-asserted-by":"crossref","first-page":"l5310","DOI":"10.1136\/bmj.l5310","article-title":"Hypertension in adults: summary of updated NICE guidance","volume":"367","author":"Boffa","year":"2019","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.amjmed.2022.05.009_bib0059","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1161\/HYPERTENSIONAHA.120.15026","article-title":"2020 international society of hypertension global hypertension practice guidelines","volume":"75","author":"Unger","year":"2020","journal-title":"Hypertension"},{"issue":"10305","key":"10.1016\/j.amjmed.2022.05.009_bib0060","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0140-6736(21)01921-8","article-title":"Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: An individual participant-level data meta-analysis","volume":"398","author":"Rahimi","year":"2021","journal-title":"Lancet"},{"issue":"18","key":"10.1016\/j.amjmed.2022.05.009_bib0061","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1056\/NEJMoa0801369","article-title":"Treatment of hypertension in patients 80 years of age or older","volume":"358","author":"Beckett","year":"2008","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1016\/j.amjmed.2022.05.009_bib0062","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1001\/jama.2016.7050","article-title":"Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged \u226575 years: a randomized clinical trial","volume":"315","author":"Williamson","year":"2016","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.amjmed.2022.05.009_bib0063","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jacc.2016.10.077","article-title":"Outcomes of intensive blood pressure lowering in older hypertensive patients","volume":"69","author":"Bavishi","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.amjmed.2022.05.009_bib0064","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.arr.2010.09.001","article-title":"Outcome instruments to measure frailty: a systematic review","volume":"10","author":"de Vries","year":"2011","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.amjmed.2022.05.009_bib0065","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.arr.2015.12.003","article-title":"Frailty assessment instruments: Systematic characterization of the uses and contexts of highly-cited instruments","volume":"26","author":"Buta","year":"2016","journal-title":"Ageing Res Rev"},{"issue":"3","key":"10.1016\/j.amjmed.2022.05.009_bib0066","doi-asserted-by":"crossref","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","article-title":"Frailty in older adults: evidence for a phenotype","volume":"56","author":"Fried","year":"2001","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"1","key":"10.1016\/j.amjmed.2022.05.009_bib0067","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cger.2010.08.008","article-title":"Frailty defined by deficit accumulation and geriatric medicine defined by frailty","volume":"27","author":"Rockwood","year":"2011","journal-title":"Clin Geriatr Med"},{"key":"10.1016\/j.amjmed.2022.05.009_bib0068","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1471-2318-8-24","article-title":"A standard procedure for creating a frailty index","volume":"8","author":"Searle","year":"2008","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.amjmed.2022.05.009_bib0069","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12916-015-0328-1","volume":"13","author":"Warwick","year":"2015","journal-title":"BMC Med"},{"issue":"5","key":"10.1016\/j.amjmed.2022.05.009_bib0070","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1001\/jamainternmed.2020.0051","article-title":"Generalizability of clinical trials supporting the 2017 american college of cardiology\/american heart association blood pressure guideline","volume":"180","author":"Anderson","year":"2020","journal-title":"JAMA Intern Med"},{"issue":"7","key":"10.1016\/j.amjmed.2022.05.009_bib0071","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.019707","article-title":"Characteristics of populations excluded from clinical trials supporting intensive blood pressure control guidelines","volume":"10","author":"Anderson","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"10.1016\/j.amjmed.2022.05.009_bib0072","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1093\/ageing\/afz072","article-title":"Is the association between blood pressure and mortality in older adults different with frailty? A systematic review and meta-analysis","volume":"48","author":"Todd","year":"2019","journal-title":"Age Ageing"},{"issue":"5","key":"10.1016\/j.amjmed.2022.05.009_bib0073","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/ageing\/afaa028","article-title":"Blood pressure in frail older adults: associations with cardiovascular outcomes and all-cause mortality","volume":"49","author":"Masoli","year":"2020","journal-title":"Age Ageing"},{"issue":"24","key":"10.1016\/j.amjmed.2022.05.009_bib0074","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1161\/CIRCULATIONAHA.116.026687","article-title":"Systolic blood pressure trajectory, frailty, and all-cause mortality >80 years of age: Cohort study using electronic health records","volume":"135","author":"Ravindrarajah","year":"2017","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.amjmed.2022.05.009_bib0075","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1161\/HYPERTENSIONAHA.121.17530","article-title":"Systolic blood pressure and mortality in community-dwelling older adults: Frailty as an effect modifier","volume":"79","author":"Kremer","year":"2022","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.amjmed.2022.05.009_bib0076","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jamda.2007.11.005","article-title":"Frailty: toward a clinical definition","volume":"9","author":"Abellan van Kan","year":"2008","journal-title":"J Am Med Dir Assoc"},{"issue":"6","key":"10.1016\/j.amjmed.2022.05.009_bib0077","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.jamcollsurg.2015.08.428","article-title":"Frailty for surgeons: review of a national institute on aging conference on frailty for specialists","volume":"221","author":"Robinson","year":"2015","journal-title":"J Am Coll Surg"},{"issue":"1","key":"10.1016\/j.amjmed.2022.05.009_bib0078","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s12877-017-0621-2","article-title":"What is polypharmacy? A systematic review of definitions","volume":"17","author":"Masnoon","year":"2017","journal-title":"BMC Geriatr"},{"issue":"1","key":"10.1016\/j.amjmed.2022.05.009_bib0079","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/s12877-018-0926-9","article-title":"Potentially inappropriate medication use among hypertensive older African-American adults","volume":"18","author":"Bazargan","year":"2018","journal-title":"BMC Geriatr"},{"issue":"8","key":"10.1016\/j.amjmed.2022.05.009_bib0080","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.2215\/CJN.01030120","article-title":"Adverse drug reactions in patients with CKD","volume":"15","author":"Laville","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12","key":"10.1016\/j.amjmed.2022.05.009_bib0081","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1046\/j.1532-5415.2002.50607.x","article-title":"Adverse drug reactions as cause of hospital admissions: results from the Italian group of pharmacoepidemiology in the elderly (GIFA)","volume":"50","author":"Onder","year":"2002","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"10.1016\/j.amjmed.2022.05.009_bib0082","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/jhh.2015.38","article-title":"Non-adherence to antihypertensive medication is very common among resistant hypertensives: results of a directly observed therapy clinic","volume":"30","author":"Hameed","year":"2016","journal-title":"J Hum Hypertens"},{"issue":"5","key":"10.1016\/j.amjmed.2022.05.009_bib0083","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1161\/HYP.0000000000000084","article-title":"Resistant hypertension: detection, evaluation, and management: A scientific statement from the american heart association","volume":"72","author":"Carey","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.amjmed.2022.05.009_bib0084","doi-asserted-by":"crossref","DOI":"10.7573\/dic.212560","article-title":"Medication adherence and treatment-resistant hypertension: a review","volume":"8","author":"Hameed","year":"2019","journal-title":"Drugs Context"},{"issue":"12","key":"10.1016\/j.amjmed.2022.05.009_bib0085","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1097\/HJH.0000000000001502","article-title":"Medication adherence among patients with apparent treatment-resistant hypertension: systematic review and meta-analysis","volume":"35","author":"Durand","year":"2017","journal-title":"J Hypertens"},{"key":"10.1016\/j.amjmed.2022.05.009_bib0086","doi-asserted-by":"crossref","unstructured":"Curneen JMG, Rabbitt L, Browne D, et al. Major disparities in patient-reported adherence compared to objective assessment of adherence using mass spectrometry: a prospective study in a tertiary-referral hypertension clinic [e-pub ahead of print]. Br J Clin Pharmacol. https:\/\/doi.org\/10.1111\/bcp.15292. accessed month day, year.","DOI":"10.1111\/bcp.15292"},{"issue":"6","key":"10.1016\/j.amjmed.2022.05.009_bib0087","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1161\/HYPERTENSIONAHA.116.08729","article-title":"Risk factors for nonadherence to antihypertensive treatment","volume":"69","author":"Gupta","year":"2017","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.amjmed.2022.05.009_bib0088","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1161\/HYPERTENSIONAHA.117.09631","article-title":"Biochemical screening for nonadherence is associated with blood pressure reduction and improvement in adherence","volume":"70","author":"Gupta","year":"2017","journal-title":"Hypertension"},{"issue":"38","key":"10.1016\/j.amjmed.2022.05.009_bib0089","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1093\/eurheartj\/eht295","article-title":"Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences","volume":"34","author":"Chowdhury","year":"2013","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.amjmed.2022.05.009_bib0090","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1161\/HYPERTENSIONAHA.121.17200","article-title":"Associations between achieved ambulatory blood pressures and its changes with adverse outcomes in resistant hypertension: Was there a J-curve for ambulatory blood pressures?","volume":"77","author":"Cardoso","year":"2021","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.amjmed.2022.05.009_bib0091","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002538","article-title":"Blood pressure-lowering treatment strategies based on cardiovascular risk versus blood pressure: A meta-analysis of individual participant data","volume":"15","author":"Karmali","year":"2018","journal-title":"PLoS Med"},{"key":"10.1016\/j.amjmed.2022.05.009_bib0092","article-title":"The diastolic blood pressure J-curve revisited: an update","volume":"12","author":"Filippone","year":"2021","journal-title":"Am Heart J Plus: Cardiol Res Pract"},{"issue":"8100","key":"10.1016\/j.amjmed.2022.05.009_bib0093","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S0140-6736(78)92288-2","article-title":"Re-examination of some of the Framingham blood-pressure data","volume":"312","author":"Anderson","year":"1978","journal-title":"Lancet"},{"issue":"8121","key":"10.1016\/j.amjmed.2022.05.009_bib0094","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0140-6736(79)91274-1","article-title":"Relation of reduction in pressure to first myocardial infarction in patients receiving treatment for severe hypertension","volume":"313","author":"Stewart","year":"1979","journal-title":"Lancet"},{"issue":"20","key":"10.1016\/j.amjmed.2022.05.009_bib0095","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/j.jacc.2009.05.073","article-title":"The J-curve between blood pressure and coronary artery disease or essential hypertension: exactly how essential?","volume":"54","author":"Messerli","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"10056","key":"10.1016\/j.amjmed.2022.05.009_bib0096","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1016\/S0140-6736(16)31326-5","article-title":"Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort study","volume":"388","author":"Vidal-Petiot","year":"2016","journal-title":"Lancet"},{"issue":"21","key":"10.1016\/j.amjmed.2022.05.009_bib0097","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1001\/jama.290.21.2805","article-title":"A calcium antagonist vs a non\u2013calcium antagonist hypertension treatment strategy for patients with coronary artery disease: the international verapamil-trandolapril study (INVEST): A randomized controlled trial","volume":"290","author":"Pepine","year":"2003","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.amjmed.2022.05.009_bib0098","doi-asserted-by":"crossref","first-page":"884","DOI":"10.7326\/0003-4819-144-12-200606200-00005","article-title":"Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous?","volume":"144","author":"Messerli","year":"2006","journal-title":"Ann Intern Med"},{"issue":"17","key":"10.1016\/j.amjmed.2022.05.009_bib0099","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1093\/eurheartj\/ehaa132","article-title":"Myocardial reperfusion reverses the J-curve association of cardiovascular risk and diastolic blood pressure in patients with left ventricular dysfunction and heart failure after myocardial infarction: Insights from the EPHESUS trial","volume":"41","author":"B\u00f6hm","year":"2020","journal-title":"Eur Heart J"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934322004041?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934322004041?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T09:27:53Z","timestamp":1757582873000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934322004041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":99,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S0002934322004041"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2022.05.009","relation":{},"ISSN":["0002-9343"],"issn-type":[{"type":"print","value":"0002-9343"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Controversies in Hypertension II: The Optimal Target Blood Pressure","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2022.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}